243 results found for “C-S4CPR-2402 Examsfragen 🍊 C-S4CPR-2402 Pruefungssimulationen 🆑 C-S4CPR-2402 Schulungsunterlagen 🌲 Suchen Sie jetzt auf ➠ www.itzert.com 🠰 nach [ C-S4CPR-2402 ] um den kostenlosen Download zu erhalten 🥠C-S4CPR-2402 Testing Engine”

Therapeutic Areas

https://carterra-bio.com/applications/therapeutic-areas/

Therapeutic Areas in Drug Discovery & Clinical Research…

Carterra Inc. Raises $10M from Telegraph Hill Partners to Develop and Launch Next-Generation Antibody Characterization Platform

https://carterra-bio.com/news/carterra-inc-raises-10m-from-telegraph-hill-partners-to-develop-and-launch-next-generation-antibody-characterization-platform/

…San Diego, CA, invests in innovative commercial stage life science, medical technology and healthcare companies. For further information, please contact: Julian Abery VP Marketing P: 919-724-0946 Carterra, Inc. info@carterra-bio.com www.carterra-bio.com

2019 Carterra Symposia

https://carterra-bio.com/news/2019-carterra-symposia/

…by artefactual complexity introduced by poor assay design or poorly behaved antibodies. Furthermore, epitope competition is not always a binary process of block or not block, and should instead be…

Science: Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study

https://carterra-bio.com/resources/defining-variant-resistant-epitopes-targeted-by-sars-cov-2-antibodies-a-global-consortium-study/

…map the epitope landscape on the SARS-CoV-2 Spike, defining and structurally illustrating seven receptor-binding domain (RBD)-directed antibody communities with distinct footprints and competition profiles. Pseudovirion-based neutralization assays reveal Spike mutations,…

Icosagen Acquires the Carterra LSA Instrument to Significantly Enhance Its Antibody Screening Capabilities in the Discovery and Development of New Therapeutic and Diagnostic Antibodies

https://carterra-bio.com/news/icosagen-acquires-the-carterra-lsa-instrument-to-significantly-enhance-its-antibody-screening-capabilities-in-the-discovery-and-development-of-new-therapeutic-and-diagnostic-antibodies/

…+372 7377 084 Website: http://www.icosagen.com/services/ — crdmo@icosagen.com About Carterra, Inc. Carterra, Inc. is a privately held company and is the leading provider of high-throughput technologies designed to accelerate and improve…

Antibody Engineering & Therapeutics Europe – Amsterdam

https://carterra-bio.com/antibody-engineering-therapeutics-europe-amsterdam/

Antibody Engineering & Therapeutics Europe – Amsterdam…

LakePharma Expands Service Capability with Purchase of Carterra High Throughput Antibody Characterization LSA™ Instrumentation

https://carterra-bio.com/news/lakepharma-expands-service-capability-with-purchase-of-carterra-high-throughput-antibody-characterization-lsa-instrumentation/

…so that unique epitopes and potential novel therapeutic candidates can be identified, while expanding and enhancing IP coverage. info@carterra-bio.com www.carterra-bio.com About LakePharma LakePharma is the leading US-based biologics company specializing…

Bispecific Antibodies Potently Neutralize SARS-CoV-2 Variants of Concern – Presentation by NIH Scientists

https://carterra-bio.com/resources/bispecific-antibodies-potently-neutralize-sars-cov-2-variants-of-concern/

…a competition assay of all the antibodies versus each other in this checkerboard format. And here, red means that there is competition and green means there is not. And so,…

Wasatch Microfluidics Announces Name Change to Carterra Inc. and New High Throughput SPR Instrument

https://carterra-bio.com/news/wasatch-microfluidics-announces-name-change-to-carterra-inc-and-new-high-throughput-spr-instrument/

…is developing the next generation of label-free biosensors for drug discovery and life science research. For further information, please contact: Josh Eckman CEO P: 844-642-7635 x700 Carterra, Inc. info@carterra-bio.com www.carterra-bio.com

The new LSA-XT and high-throughput SPR characterization of multi-specific antibodies

https://carterra-bio.com/resources/the-new-lsa-xt-and-high-throughput-spr-characterization-of-multi-specific-antibodies/

…zone are non-competitive antibody. So they’re not competing with the one on the spot. And the one in the red zone, or pinkish red zone, are the one which is…

Back to Top